| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.94 | $88.34 (0%) | 🛒 Add to cart |
| 60 | $2.53 | $176.68 $151.58 (14%) | 🛒 Add to cart |
| 90 | $2.39
Best per pill | $265.02 $214.83 (19%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Tizanidine: Targeted Spasticity Relief for Neurological Conditions - Evidence-Based Review
Tizanidine hydrochloride is a short-acting muscle relaxant that has become a cornerstone in managing spasticity across multiple neurological conditions. As a centrally acting alpha-2 adrenergic receptor agonist, it works primarily at the spinal cord level to reduce excessive muscle tone by inhibiting the release of excitatory neurotransmitters. Available in both immediate-release (2mg, 4mg) and extended-release (2mg, 4mg, 6mg) formulations, this medication represents a significant advancement over older muscle relaxants due to its more targeted mechanism and generally favorable side effect profile when dosed appropriately.
baclofen
Baclofen represents one of those fascinating clinical tools that sits at the intersection of neurology, addiction medicine, and rehabilitation. As a GABA-B receptor agonist, it’s structurally similar to the inhibitory neurotransmitter GABA but with a much more targeted mechanism. What began as an antispasticity medication has evolved into something much more complex in clinical practice. I remember my first encounter with baclofen during residency – we had a patient with severe spinal cord injury whose muscle spasms were so violent they’d literally throw him out of his wheelchair.
Ciplox: Potent Broad-Spectrum Antibacterial Therapy - Evidence-Based Review
Ciprofloxacin, commonly encountered in clinical practice under various brand names including Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where other classes had begun to falter due to rising resistance patterns. In hospital formularies and outpatient settings alike, it’s often a go-to for clinicians dealing with everything from stubborn urinary tract infections to more systemic issues, though its use has become more nuanced over the years due to safety profile considerations.
cipro
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic that has been a cornerstone in treating bacterial infections since its introduction in the 1980s. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, and repair. Available in oral tablets, intravenous formulations, and ophthalmic/otic solutions, Cipro is prescribed for a wide range of infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections, particularly when caused by multidrug-resistant pathogens.
flexeril
Cyclobenzaprine hydrochloride - a centrally-acting skeletal muscle relaxant that’s been in our toolkit since the 1970s, though we still debate its exact mechanism. What’s fascinating is how this tricyclic compound structurally resembles amitriptyline but somehow manages to provide muscle relaxation without the same degree of sedation, at least in theory. The reality in clinical practice is often more nuanced. Flexeril: Targeted Muscle Spasm Relief with Central Action - Evidence-Based Review 1.
lioresal
Baclofen, marketed under the brand name Lioresal among others, is a medication primarily used to treat spasticity. It is a central nervous system (CNS) depressant and acts as a GABAB receptor agonist. This agent represents a cornerstone in the management of muscle spasticity resulting from conditions such as multiple sclerosis, spinal cord injuries, and cerebral palsy. Unlike peripheral muscle relaxants, baclofen exerts its effects directly within the spinal cord and brain, modulating neurotransmitter release to reduce excessive muscle tone and spasms.
robaxin
Let me tell you about Robaxin - that’s methocarbamol for those who prefer the generic name. I’ve been working with this muscle relaxant for over fifteen years now, and it’s one of those medications that’s both straightforward and surprisingly nuanced in clinical practice. When patients come in with those acute musculoskeletal spasms that make every movement painful, Robaxin often becomes our first-line defense, particularly when we want to avoid the sedation issues we see with some of the other options.
skelaxin
Metaxalone, a centrally acting skeletal muscle relaxant, has been part of our musculoskeletal toolkit for decades. It’s one of those older drugs that doesn’t get the flashy new studies but has persisted in formularies because, in the right patient, it just works with a relatively favorable side effect profile compared to some alternatives. It’s not a benzodiazepine derivative, which is a key point, and its exact mechanism has been a topic of discussion—we’ll get into that.
zanaflex
Tizanidine hydrochloride - that’s the generic name we’re discussing here, though most people know it as Zanaflex. It’s one of those medications that sits in that interesting space between muscle relaxants and central alpha-2 adrenergic agonists. What’s fascinating about tizanidine is how it evolved from being just another potential antihypertensive to becoming a first-line choice for spasticity management. The story actually begins in the 1980s when researchers at Sandoz were investigating novel compounds for blood pressure control, and they stumbled upon this unique agent that showed remarkable muscle-relaxing properties without the significant cardiovascular effects they’d anticipated.